{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:35:40Z","timestamp":1757540140289},"reference-count":0,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"vor","delay-in-days":15192,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[1974,6]]},"abstract":"<jats:p>The effect of oral naloxone on the analgesic efficacy and side effects of oral methadone was examined in one hundred patients with postoperative pain. Doses of methadone of 5 mg and 15 mg were compared with combinations containing the same amount of methadone plus one\u2010tenth as much naloxone. No consistent or statistically significant effect of naloxone was detected on analgesia, sedation, or side effects. However, the statistical power of this study was low, its chance of detecting a real difference of 20% being at best 10%. To increase this chance to 95%, nearly 4,500 subiects would be needed. This analysis has implications for the general problem of testing drug equivalence.<\/jats:p>","DOI":"10.1002\/cpt1974156556","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T01:30:10Z","timestamp":1451957410000},"page":"556-564","source":"Crossref","is-referenced-by-count":5,"title":["Effect of naloxone on the analgesic activity of methadone in a 1:10 oral combination; Time and cost of flirting with the null hypothesis in tests of equivalence"],"prefix":"10.1111","volume":"15","author":[{"given":"J. F.","family":"Calimlim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. M.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Lasagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. T.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,4]]},"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt1974156556","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt1974156556","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt1974156556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:32:02Z","timestamp":1699363922000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt1974156556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1974,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1974,6]]}},"alternative-id":["10.1002\/cpt1974156556"],"URL":"https:\/\/doi.org\/10.1002\/cpt1974156556","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1974,6]]}}}